SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,640.55 |
| Enterprise Value ($M) | 1,187.09 |
| Book Value ($M) | 681.43 |
| Book Value / Share | 5.18 |
| Price / Book | 2.41 |
| NCAV ($M) | 545.68 |
| NCAV / Share | 4.15 |
| Price / NCAV | 3.01 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.02 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.34 |
| Current Ratio | 13.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 926.24 |
| Assets | 1,061.99 |
| Liabilities | 380.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Kynam Capital Management, LP | 6.34 | ||
| 13G/A | BlackRock, Inc. | 16.00 | 0.00 | |
| 13D/A | Deep Track Capital, LP | 13.60 | 42.03 | |
| 13G/A | State Street Corp | 5.90 | -19.01 | |
| 13G/A | Federated Hermes, Inc. | 4.70 | -45.81 | |
| 13G/A | Vanguard Group Inc | 7.18 | 11.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 317,073 | 1,088,357 | 29.13 | |
| 284,693 | 1,162,488 | 24.49 | |
| 305,860 | 1,242,780 | 24.61 | |
| 270,755 | 1,249,601 | 21.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DAWN – Day One Biopharmaceuticals, Inc. | DNLI – Denali Therapeutics Inc. |
| DSGN – Design Therapeutics, Inc. | EDIT – Editas Medicine, Inc. |
| ELEV – Elevation Oncology, Inc. |